Praxis Precision Medicines, Inc. (PRAX) Tops Q3 EPS by 8c

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) reported Q3 EPS of ($0.18), $0.08 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $470 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Praxis Precision Medicines, Inc. (PRAX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• MakeMyTrip (MMYT) PT Raised to $84 at Goldman Sachs
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance